Rapid induction of complete molecular remission by sequential therapy with LDAC and sorafenib in FLT3-ITD-positive patients unfit for intensive treatment: two cases and review of the literature

Treatment of acute myeloid leukemia remains a therapeutic challenge. Even in younger patients with a low rate of co-morbidities less than 50% of patients can be cured. For older patients or patients with significant co-morbidities, the situation appears even worse. In patients not eligible for inten...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolleschak, Denise, Schalk, Enrico, Krogel, Christian, Schnoeder, Tina M, Luehr, Helga, Jentsch-Ullrich, Kathleen, Fischer, Thomas, Heidel, Florian H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686641/
https://www.ncbi.nlm.nih.gov/pubmed/23759001
http://dx.doi.org/10.1186/1756-8722-6-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686641/
https://www.ncbi.nlm.nih.gov/pubmed/23759001
http://dx.doi.org/10.1186/1756-8722-6-39

Ejemplares similares